There is no cure at this time for CLL (Chronic Lymphocytic Leukemia). An NCI (National Cancer Institute) trial for a kinase inhibitor has the potential for finding that cure. In order to continue the trial, NIH funding must be increased from $30.7 billion to $33 billion.
This is historical material “frozen in time”. The website is no longer updated and links to external websites and some internal pages may not work.
